Bausch Health Companies Inc. Tax Withholding Paid on Stock Awards
Bausch Health Companies Inc. (BHC) reported Tax Withholding Paid on Stock Awards of $42.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-07-30
- Bausch Health Companies Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $8.00M, a 166.67% increase year-over-year.
- Bausch Health Companies Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $34.00M, a 112.50% increase year-over-year.
- Bausch Health Companies Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Bausch Health Companies Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $5.00M, a 0.00% change year-over-year.
- Bausch Health Companies Inc. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $24.00M, a 7.69% decline from fiscal 2024.
- Bausch Health Companies Inc. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $26.00M, a 8.33% increase from fiscal 2023.
- Bausch Health Companies Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $24.00M, a 22.58% decline from fiscal 2022.
- Bausch Health Companies Inc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $31.00M, a 40.38% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 3 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 12 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $42.00M 10-Q · filed 2026-07-30 | $42.00M derived: sum of 3 quarters · filed 2026-07-30 | $47.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $34.00M 10-Q · filed 2026-04-30 | $34.00M derived: sum of 2 quarters · filed 2026-04-30 | $39.00M derived: sum of 3 quarters · filed 2026-04-30 | $42.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $5.00M derived: sum of 2 quarters · filed 2026-02-19 | $8.00M derived: sum of 3 quarters · filed 2026-07-30 | $24.00M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $8.00M derived: sum of 2 quarters · filed 2026-07-30 | $24.00M 10-Q · filed 2025-10-30 | $27.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $19.00M 10-Q · filed 2026-07-30 | $22.00M derived: sum of 3 quarters · filed 2026-07-30 | $27.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $16.00M 10-Q · filed 2026-04-30 | $19.00M derived: sum of 2 quarters · filed 2026-04-30 | $24.00M derived: sum of 3 quarters · filed 2026-04-30 | $28.00M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $8.00M derived: sum of 2 quarters · filed 2026-02-19 | $12.00M derived: sum of 3 quarters · filed 2026-02-19 | $26.00M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $9.00M derived: sum of 2 quarters · filed 2025-10-30 | $23.00M 10-Q · filed 2025-10-30 | $24.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $18.00M 10-Q · filed 2025-07-31 | $19.00M derived: sum of 3 quarters · filed 2026-02-19 | $27.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | $14.00M 10-Q · filed 2025-05-01 | $15.00M derived: sum of 2 quarters · filed 2026-02-19 | $23.00M derived: sum of 3 quarters · filed 2026-02-19 | $26.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $9.00M derived: sum of 2 quarters · filed 2026-02-19 | $12.00M derived: sum of 3 quarters · filed 2026-02-19 | $24.00M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $11.00M derived: sum of 2 quarters · filed 2024-10-31 | $23.00M 10-Q · filed 2024-10-31 | $24.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $15.00M 10-Q · filed 2024-08-01 | $16.00M derived: sum of 3 quarters · filed 2025-02-20 | $17.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $12.00M 10-Q · filed 2024-05-02 | $13.00M derived: sum of 2 quarters · filed 2025-02-20 | $14.00M derived: sum of 3 quarters · filed 2025-02-20 | $18.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $2.00M derived: sum of 2 quarters · filed 2025-02-20 | $6.00M derived: sum of 3 quarters · filed 2025-02-20 | $31.00M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $5.00M derived: sum of 2 quarters · filed 2023-11-02 | $30.00M 10-Q · filed 2023-11-02 | $34.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $29.00M 10-Q · filed 2023-08-03 | $33.00M derived: sum of 3 quarters · filed 2024-02-22 | $36.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $25.00M 10-Q · filed 2023-05-04 | $29.00M derived: sum of 2 quarters · filed 2024-02-22 | $32.00M derived: sum of 3 quarters · filed 2024-02-22 | $36.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $7.00M derived: sum of 2 quarters · filed 2024-02-22 | $11.00M derived: sum of 3 quarters · filed 2024-02-22 | $52.00M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $7.00M derived: sum of 2 quarters · filed 2022-11-03 | $48.00M 10-Q · filed 2022-11-03 | $48.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $45.00M 10-Q · filed 2022-08-09 | $45.00M derived: sum of 3 quarters · filed 2023-02-23 | $46.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $41.00M 10-Q · filed 2022-05-10 | $41.00M derived: sum of 2 quarters · filed 2023-02-23 | $42.00M derived: sum of 3 quarters · filed 2023-02-23 | $47.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.00M derived: sum of 2 quarters · filed 2023-02-23 | $6.00M derived: sum of 3 quarters · filed 2023-02-23 | $30.00M 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $6.00M derived: sum of 2 quarters · filed 2021-11-02 | $30.00M 10-Q · filed 2021-11-02 | $30.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $29.00M 10-Q · filed 2021-08-03 | $29.00M derived: sum of 3 quarters · filed 2022-05-11 | $30.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-03-31 | $24.00M 10-Q · filed 2021-05-04 | $24.00M derived: sum of 2 quarters · filed 2022-05-11 | $25.00M derived: sum of 3 quarters · filed 2022-05-11 | $30.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2019-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $1.00M derived: sum of 2 quarters · filed 2022-05-11 | $6.00M derived: sum of 3 quarters · filed 2022-05-11 | $40.00M 8-K · filed 2022-05-11 | ||||
| 2019-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $6.00M derived: sum of 2 quarters · filed 2020-11-03 | $40.00M 10-Q · filed 2020-11-03 | $40.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $39.00M 10-Q · filed 2020-08-06 | $39.00M derived: sum of 3 quarters · filed 2021-05-04 | $41.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | $34.00M 10-Q · filed 2020-05-07 | $34.00M derived: sum of 2 quarters · filed 2021-05-04 | $36.00M derived: sum of 3 quarters · filed 2021-05-04 | $39.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | $2.00M derived: sum of 2 quarters · filed 2021-05-04 | $5.00M derived: sum of 3 quarters · filed 2021-05-04 | $10.00M 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $5.00M derived: sum of 2 quarters · filed 2019-11-04 | $10.00M 10-Q · filed 2019-11-04 | $10.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $8.00M 10-Q · filed 2019-08-06 | $8.00M derived: sum of 3 quarters · filed 2020-02-19 | $9.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $5.00M 10-Q · filed 2019-05-06 | $5.00M derived: sum of 2 quarters · filed 2020-02-19 | $6.00M derived: sum of 3 quarters · filed 2020-02-19 | $9.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $1.00M derived: sum of 2 quarters · filed 2020-02-19 | $4.00M derived: sum of 3 quarters · filed 2020-02-19 | $4.00M 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $4.00M derived: sum of 2 quarters · filed 2018-11-06 | $4.00M 10-Q · filed 2018-11-06 | $6.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $3.00M 10-Q · filed 2018-08-07 | $5.00M derived: sum of 3 quarters · filed 2019-02-20 | $7.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-08 | $2.00M derived: sum of 2 quarters · filed 2019-02-20 | $4.00M derived: sum of 3 quarters · filed 2019-02-20 | $3.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $4.00M derived: sum of 2 quarters · filed 2019-02-20 | $3.00M derived: sum of 3 quarters · filed 2019-02-20 | $11.00M 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.00M derived: sum of 2 quarters · filed 2017-11-07 | $9.00M 10-Q · filed 2017-11-07 | $9.10M 10-Q · filed 2016-11-09 | $11.20M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $7.00M 10-Q · filed 2017-08-08 | $7.30M 10-Q · filed 2016-08-09 | $9.20M derived: sum of 3 quarters · filed 2018-08-10 | $33.50M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-03-31 | $8.00M 10-Q · filed 2017-05-09 | $7.70M 10-Q · filed 2016-06-07 | $10.20M derived: sum of 2 quarters · filed 2018-08-10 | $34.50M derived: sum of 3 quarters · filed 2018-08-10 | $80.10M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | $2.20M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $26.50M derived: sum of 2 quarters · filed 2018-08-10 | $72.10M derived: sum of 3 quarters · filed 2018-08-10 | $88.00M 8-K · filed 2018-08-10 | ||||
| 2015-09-30 | $24.30M 10-Q · filed 2015-10-26 | $69.90M derived: sum of 2 quarters · filed 2015-10-26 | $85.80M 10-Q · filed 2016-11-09 | $91.30M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $45.60M 10-Q · filed 2015-07-28 | $61.50M 10-Q · filed 2016-08-09 | $67.00M derived: sum of 3 quarters · filed 2017-03-01 | $69.00M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $15.90M 10-Q · filed 2016-06-07 | $21.40M derived: sum of 2 quarters · filed 2017-03-01 | $23.40M derived: sum of 3 quarters · filed 2017-03-01 | $32.20M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $7.50M derived: sum of 2 quarters · filed 2017-03-01 | $16.30M derived: sum of 3 quarters · filed 2017-03-01 | $44.00M 10-K · filed 2017-03-01 | $44.10M 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $2.00M 10-Q · filed 2015-10-26 | $10.80M derived: sum of 2 quarters · filed 2015-10-26 | $38.50M 10-Q · filed 2015-10-26 | $68.10M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $8.80M 10-Q · filed 2015-07-28 | $36.50M 10-Q · filed 2015-07-28 | $66.10M derived: sum of 3 quarters · filed 2016-04-29 | $80.50M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $27.70M 10-Q · filed 2015-04-30 | $57.30M derived: sum of 2 quarters · filed 2016-04-29 | $71.70M derived: sum of 3 quarters · filed 2016-04-29 | $86.40M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $29.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $44.00M derived: sum of 2 quarters · filed 2016-04-29 | $58.70M derived: sum of 3 quarters · filed 2016-04-29 | $65.50M 10-K · filed 2016-04-29 | $65.50M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $14.40M 10-Q · filed 2014-10-24 | $14.39M 10-Q · filed 2013-11-01 | $29.10M derived: sum of 2 quarters · filed 2014-10-24 | $35.90M 10-Q · filed 2014-10-24 | $35.92M 10-Q · filed 2013-11-01 | $45.89M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $14.70M 10-Q · filed 2014-08-01 | $14.68M 10-Q · filed 2013-08-07 | $21.50M 10-Q · filed 2014-08-01 | $21.53M 10-Q · filed 2013-08-07 | $31.49M derived: sum of 3 quarters · filed 2015-02-25 | $38.87M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $6.80M 10-Q · filed 2014-05-09 | $6.85M 10-Q · filed 2013-05-03 | $16.79M derived: sum of 2 quarters · filed 2015-02-25 | $24.17M derived: sum of 3 quarters · filed 2015-02-25 | $34.08M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $9.99M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $17.37M derived: sum of 2 quarters · filed 2015-02-25 | $27.28M derived: sum of 3 quarters · filed 2015-02-25 | $31.10M 10-K · filed 2015-02-25 | $31.07M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $7.38M 10-Q · filed 2013-11-01 | $17.29M derived: sum of 2 quarters · filed 2013-11-01 | $21.11M 10-Q · filed 2013-11-01 | $23.67M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $9.91M 10-Q · filed 2013-08-07 | $13.73M 10-Q · filed 2013-08-07 | $16.30M derived: sum of 3 quarters · filed 2014-02-28 | $18.77M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $3.82M 10-Q · filed 2013-05-03 | $6.39M derived: sum of 2 quarters · filed 2014-02-28 | $8.86M derived: sum of 3 quarters · filed 2014-02-28 | $24.06M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $5.04M derived: sum of 2 quarters · filed 2014-02-28 | $20.24M derived: sum of 3 quarters · filed 2014-02-28 | $59.72M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $2.48M 10-Q · filed 2012-11-05 | $17.68M derived: sum of 2 quarters · filed 2012-11-05 | $57.16M 10-Q · filed 2012-11-05 | |||||
| 2011-06-30 | $15.20M 10-Q · filed 2012-08-03 | $54.68M 10-Q · filed 2012-08-03 | ||||||
| 2011-03-31 | $39.48M 10-Q · filed 2012-05-04 | |||||||
| 2010-12-31 | $14.48M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |